Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of schizophrenia~* Ability to remain hospitalized for at least first 4 weeks of study~* Needs hospitalization due to worsening of schizophrenia~Exclusion Criteria:~* Type 1 or 2 diabetes~* Previous use of clozapine~* Serious medical illness other than schizophrenia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).